4th German-Scandinavian Meeting on Movement Disorders

Abstracts (HTML) List of Authors

Aebischer, P.

Analysis of alpha-synuclein aggregation and associated pathologies in a cellular model of multiple system atrophy

Agnati, L.

Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for l-dopa induced dyskinesias

Andersson, D.

Nigral dopamine release – preclinical studies of its implication in motor functions

Antonelli, T.

Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for l-dopa induced dyskinesias

Bagnato, S.

Transcranial magnetic stimulation of the motor sytem in focal dystonia

Baier, P. C.

The possible role of Dopamine D3 receptor antagonism on motor activity in rats

Baron, R.

Idiopathic restless legs syndrome: Abnormalities in central somatosensory processing

Benecke, R.

Clinical differential diagnosis of parkinsonism

Berding, G.

Imaging of central cannabinoid CB1 receptors, a potential target for therapeutic agents in movement disorders

Bergquist, F.

Nigral dopamine release – preclinical studies of its implication in motor functions

Binder, A.

Idiopathic restless legs syndrome: Abnormalities in central somatosensory processing

Björklund, A.

Gene therapy for Parkinson's disease: now getting closer

Blau, N.

Hereditary dystonia or parkinson – a patient with both – and problems concerning diagnostic, treatment and genetic counselling

Bode, A.

Idiopathic restless legs syndrome: Abnormalities in central somatosensory processing

Brundin, P.

Adult stem cell therapy – an option for the brain?

Buchert, R.

Imaging of central cannabinoid CB1 receptors, a potential target for therapeutic agents in movement disorders

Deuschl, G.

Microelectrode recordings from Patients with Parkinson-Disease
Microglia as a posible pathomechanism in Parkinson's diseases
Treatment guidelines of the Movement Disorder Society for deep brain stimulation for Parkinson's Disease
Idiopathic restless legs syndrome: Abnormalities in central somatosensory processing
Focal Hand Dystonia: A Functional Imaging Study

Dietrichs, E.

The prevalence of focal/segmental dystonia and HFS in Oslo

Double, K.

News from substantia nigra neuromelanin

Emrich, H. M.

Imaging of central cannabinoid CB1 receptors, a potential target for therapeutic agents in movement disorders

Fedorow, H.

News from substantia nigra neuromelanin

Ferraro, L.

Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for l-dopa induced dyskinesias

Fillon, G.

Analysis of alpha-synuclein aggregation and associated pathologies in a cellular model of multiple system atrophy

Friberg, L.

Bladder dysfunction in IPD and atypical Parkinsonian disorders – pathophysiology and treatment
Hereditary dystonia or parkinson – a patient with both – and problems concerning diagnostic, treatment and genetic counselling

Fuxe, K.

Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for l-dopa induced dyskinesias

Gerlach, M.

News from substantia nigra neuromelanin

Gielow, P.

Imaging of central cannabinoid CB1 receptors, a potential target for therapeutic agents in movement disorders

Haass, C.

Analysis of alpha-synuclein aggregation and associated pathologies in a cellular model of multiple system atrophy

Haeckel, O.

KATP channels control the differential vulnerability of dopaminergic midbrain neurons in a chronic MPTP-model of Parkinson's disease

Hertz, J. M.

Hereditary dystonia or parkinson – a patient with both – and problems concerning diagnostic, treatment and genetic counselling

Herzog, J.

Microelectrode recordings from Patients with Parkinson-Disease
Treatment guidelines of the Movement Disorder Society for deep brain stimulation for Parkinson's Disease

Hisch, E. C.

Stem cell deficiency in Parkinson's disease

Hjermind, L. E.

Hereditary dystonia or parkinson – a patient with both – and problems concerning diagnostic, treatment and genetic counselling

Höglinger, G. U.

Stem cell deficiency in Parkinson's disease

Johannsen, L. G.

Hereditary dystonia or parkinson – a patient with both – and problems concerning diagnostic, treatment and genetic counselling

Kahle, P. J.

Analysis of alpha-synuclein aggregation and associated pathologies in a cellular model of multiple system atrophy

Kerty, E.

Quality of life in patients with cervical dystonia

Knapp, W. H.

Imaging of central cannabinoid CB1 receptors, a potential target for therapeutic agents in movement disorders

Knutzen, A.

Focal Hand Dystonia: A Functional Imaging Study

Koch, R.

The possible role of Dopamine D3 receptor antagonism on motor activity in rats

Kretzschmar, H. A.

Analysis of alpha-synuclein aggregation and associated pathologies in a cellular model of multiple system atrophy

Le, K. D.

The prevalence of focal/segmental dystonia and HFS in Oslo

Li, J. Y.

Adult stem cell therapy – an option for the brain?

Liss, B.

KATP channels control the differential vulnerability of dopaminergic midbrain neurons in a chronic MPTP-model of Parkinson's disease

Lubetzki, C.

Analysis of alpha-synuclein aggregation and associated pathologies in a cellular model of multiple system atrophy

Lucius, R.

Microglia as a posible pathomechanism in Parkinson's diseases

Lucking, C. B.

Hereditary dystonia or parkinson – a patient with both – and problems concerning diagnostic, treatment and genetic counselling

Ludolph, A.

High dose dopamine agonist treatment and combination of dopamine agonists

Malt, U. F.

Quality of life in patients with cervical dystonia

Mehdorn, H. M.

Microelectrode recordings from Patients with Parkinson-Disease

Miki, T.

KATP channels control the differential vulnerability of dopaminergic midbrain neurons in a chronic MPTP-model of Parkinson's disease

Müller-Vahl, K.

Imaging of central cannabinoid CB1 receptors, a potential target for therapeutic agents in movement disorders

Møller, L. B.

TH mutations in dopa-responsiv dystonia

Neumann, M.

Analysis of alpha-synuclein aggregation and associated pathologies in a cellular model of multiple system atrophy

Nielsen, J. E.

Hereditary dystonia or parkinson – a patient with both – and problems concerning diagnostic, treatment and genetic counselling
Molecular and genetic aspects of hereditary spastic paraplegia

Nielsen, K. K.

Bladder dysfunction in IPD and atypical Parkinsonian disorders – pathophysiology and treatment

Nilsen, B.

The prevalence of focal/segmental dystonia and HFS in Oslo

Nilsson, A. C.

Molecular pathophysiology of L-DOPA-induced dyskinesia

Nissbrandt, H.

Nigral dopamine release – preclinical studies of its implication in motor functions

Nyholm, D.

Continuous L-dopa infusion

Odin, P.

High dose dopamine agonist treatment and combination of dopamine agonists

Oehlwein, C.

High dose dopamine agonist treatment and combination of dopamine agonists

Oertel, W. H.

Stem cell deficiency in Parkinson's disease

Paul, G.

Adult stem cell therapy – an option for the brain?

Peller, M.

Focal Hand Dystonia: A Functional Imaging Study

Polzer, U.

High dose dopamine agonist treatment and combination of dopamine agonists

Quartarone, A.

Transcranial magnetic stimulation of the motor sytem in focal dystonia

Regeur, L.

Hereditary dystonia or parkinson – a patient with both – and problems concerning diagnostic, treatment and genetic counselling
Gilles de la Tourette's Syndrome – an update of drug treatment

Reichmann, H.

Disturbances of the Autonomic Nervous System in PD Patients

Renner, R.

High dose dopamine agonist treatment and combination of dopamine agonists

Riederer, P.

News from substantia nigra neuromelanin

Rizk, P.

Stem cell deficiency in Parkinson's disease

Rizzo, V.

Transcranial magnetic stimulation of the motor sytem in focal dystonia

Roeper, J.

KATP channels control the differential vulnerability of dopaminergic midbrain neurons in a chronic MPTP-model of Parkinson's disease

Rothwell, J.

Transcranial magnetic stimulation of the motor sytem in focal dystonia

Roybon, L.

Adult stem cell therapy – an option for the brain?

Schattschneider, J.

Idiopathic restless legs syndrome: Abnormalities in central somatosensory processing

Schneider, U.

Imaging of central cannabinoid CB1 receptors, a potential target for therapeutic agents in movement disorders

Schüler, P.

High dose dopamine agonist treatment and combination of dopamine agonists

Seino, S.

KATP channels control the differential vulnerability of dopaminergic midbrain neurons in a chronic MPTP-model of Parkinson's disease

Shing, M.

High dose dopamine agonist treatment and combination of dopamine agonists

Siebner, H.

Transcranial magnetic stimulation of the motor sytem in focal dystonia
Focal Hand Dystonia: A Functional Imaging Study

Sievers, J.

Microglia as a posible pathomechanism in Parkinson's diseases

Skogseid, I. M.

Quality of life in patients with cervical dystonia

Steigerwald, F.

Microelectrode recordings from Patients with Parkinson-Disease

Stimpel, H.

Bladder dysfunction in IPD and atypical Parkinsonian disorders – pathophysiology and treatment

Storch, A.

High dose dopamine agonist treatment and combination of dopamine agonists

Sørensen, S. A.

Hereditary dystonia or parkinson – a patient with both – and problems concerning diagnostic, treatment and genetic counselling

Tanganelli, S.

Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for l-dopa induced dyskinesias

Tomasini, M. C.

Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for l-dopa induced dyskinesias

Trenkwalder, C.

The possible role of Dopamine D3 receptor antagonism on motor activity in rats

Tribl, F.

News from substantia nigra neuromelanin

Virley, D.

The possible role of Dopamine D3 receptor antagonism on motor activity in rats

Volkmann, J.

Microelectrode recordings from Patients with Parkinson-Disease
Treatment guidelines of the Movement Disorder Society for deep brain stimulation for Parkinson's Disease

Wasner, G.

Idiopathic restless legs syndrome: Abnormalities in central somatosensory processing

Weiss, M.

Focal Hand Dystonia: A Functional Imaging Study

Werdelin, L.

Bladder dysfunction in IPD and atypical Parkinsonian disorders – pathophysiology and treatment

Werner, G.

High dose dopamine agonist treatment and combination of dopamine agonists

Wevers, R. A.

Hereditary dystonia or parkinson – a patient with both – and problems concerning diagnostic, treatment and genetic counselling

Wildmann, J.

KATP channels control the differential vulnerability of dopaminergic midbrain neurons in a chronic MPTP-model of Parkinson's disease

Wilms, H.

Microglia as a posible pathomechanism in Parkinson's diseases

Winge, K.

Bladder dysfunction in IPD and atypical Parkinsonian disorders – pathophysiology and treatment

Winkler, C.

Cell transplantation in Parkinson's disease

Zalc, B.

Analysis of alpha-synuclein aggregation and associated pathologies in a cellular model of multiple system atrophy

Zecca, L.

Microglia as a posible pathomechanism in Parkinson's diseases

Zeuner, K.

Focal Hand Dystonia: A Functional Imaging Study

Ziemssen, T.

Disturbances of the Autonomic Nervous System in PD Patients

Zufferey, R.

Analysis of alpha-synuclein aggregation and associated pathologies in a cellular model of multiple system atrophy